Skip to Content Skip to Content
  • Campus & Community
  • With its flagship light device, Lumify Care improves patient experience from the frontline

    Penn Nursing senior Anthony Scarpone-Lambert earned a 2021 President’s Innovation Prize for his company and its first trio of products: uNight Light, the Sleep-First Education Initiative, and the uNightShift Community.
    Person in a blue button-down shirt, arms crossed, leaning against a tree outside. In the background are blurred out bushes and trees, a path and a streetlight.
    The School of Nursing’s Anthony Scarpone-Lambert of Chalfont, Pennsylvania, earned a 2021 President’s Innovation Prize for Lumify Care. The company’s first product, uNight Light, is a battery-powered, hands-free light device that magnetically clips onto scrubs, has three modes, and is easily cleanable with hospital-grade disinfectant wipes. It offers nurses an alternative to turning on overhead lights overnight, helping patients rest and making a hospital stay more conducive to healing.

    Recent Articles

  • More Articles
  • The Fed explained: What it does and why it matters
    Photo of the Federal Reserve facade

    (Image: Lance Nelson)

    The Fed explained: What it does and why it matters

    Former Philadelphia Fed President Patrick Harker and financial historian Peter Conti-Brown, both Wharton professors, unpack the central bank’s origins, its unusual structure, and the quiet ways it shapes the economy

    May 13, 2026

    Fighting oral cancer with bioengineered chewing gum
    A latex-gloved hand hoding a petri dish of medical chewing gum.

    A bioengineered bean gum from the lab of Penn Dental’s Henry Daniell is found to reduce the levels of three microbes associated with head and neck squamous cell cancer to almost zero, without affecting the beneficial bacteria normally found in the mouth.

    (Image: Kevin Monko/Penn Dental Medicine)

    Fighting oral cancer with bioengineered chewing gum

    Research led by Penn Dental’s Henry Daniell shows that antiviral and antibacterial chewing gums reduce the levels of three microbes linked to worse outcomes in oral cancers, paving the way for more effective and affordable therapies.

    Apr 20, 2026